Overview
Background
Adam G. Stewart, BBiomedSci, MBBS(Hons), MPHTM, MBiostat, FRACP, FRCPA, PhD
Dr Adam Stewart is is an Australian-trained Infectious Diseases Physician and Clinical Microbiologist. He is currently working on clinical faculty as an Assistant Professor at the University of Texas MD Anderson Cancer Center in Houston, USA. He has previously undertaken post-fellowship subspeciality training in Transplant Infectious Diseases at Massachusetts General Hospital and Harvard University. Dr Stewart is an active physician-scientist with interests in clinical trials, invasive fungal disease, and infections in oncology and transplant patients. Dr Stewart is committed to advancing the management of infections in cancer patients.
Availability
- Dr Adam Stewart is:
- Available for supervision
- Media expert
Qualifications
- Bachelor of Biomedical Science, Griffith University
- Bachelor of Medicine and Surgery and Medical Science, Griffith University
- Masters (Coursework) of Public Health and Tropical Medicine, James Cook University
Research interests
-
Invasive fungal disease
Clinical and translational research on the causes of early treatment failure and refractory infection in haematological malignancy patients
-
Fungal diagnostics
Fungal pathogenesis research; host and pathogen biomarker discovery for clinical use for diagnostic and prognostic purposes
-
Clinical trials
Novel clinical trial design for rare or uncommon pathogens including those causing invasive fungal disease
Works
Search Professor Adam Stewart’s works on UQ eSpace
2021
Journal Article
Just as good but better tolerated: posaconazole as first-line therapy for invasive aspergillosis
Stewart, Adam G. and Lane, Steven (2021). Just as good but better tolerated: posaconazole as first-line therapy for invasive aspergillosis. The Hematologist, 18 (3).
2021
Journal Article
Infectious complications of CAR T-cell therapy: a clinical update
Stewart, Adam G. and Henden, Andrea S. (2021). Infectious complications of CAR T-cell therapy: a clinical update. Therapeutic Advances in Infectious Disease, 8 204993612110367, 1-11. doi: 10.1177/20499361211036773
2021
Journal Article
How urgent is the need for new antifungals?
Stewart, Adam G. and Paterson, David L. (2021). How urgent is the need for new antifungals?. Expert Opinion on Pharmacotherapy, 22 (14), 1-14. doi: 10.1080/14656566.2021.1935868
2020
Journal Article
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa
Isler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. The Journal of Antimicrobial Chemotherapy, 76 (3), 550-560. doi: 10.1093/jac/dkaa511
2020
Journal Article
Achromobacter infections and treatment options
Isler, Burcu, Kidd, Timothy J., Stewart, Adam G., Harris, Patrick and Paterson, David L. (2020). Achromobacter infections and treatment options. Antimicrobial Agents and Chemotherapy, 64 (11) e01025, 1-16. doi: 10.1128/aac.01025-20
2020
Journal Article
Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysis
Isler, Burcu, Ezure, Yukiko, García-Fogeda Romero, Jose Luis, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy, 65 (1) e01052-20. doi: 10.1128/AAC.01052-20
2020
Journal Article
Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia
Stewart, Adam G., Burnard, Delaney, Sowden, David and McMillan, David (2020). Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia. Pathology, 52 (6), 694-699. doi: 10.1016/j.pathol.2020.06.006
2020
Journal Article
Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections
Stewart, Adam G., Harris, Patrick N. A., Chatfield, Mark, Evans, Scott R., van Duin, David and Paterson, David L. (2020). Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections. Clinical Infectious Diseases, 71 (2), 433-439. doi: 10.1093/cid/ciz1132
2020
Journal Article
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections
Stewart, Adam G., Harris, Patrick N. A., Henderson, Andrew, Schembri, Mark A. and Paterson, David L. (2020). Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. Journal of Antimicrobial Chemotherapy, 75 (9), 2384-2393. doi: 10.1093/jac/dkaa183
2020
Journal Article
New treatment options for multiresistant gram negatives
Paterson, David L., Isler, Burcu and Stewart, Adam (2020). New treatment options for multiresistant gram negatives. Current Opinion in Infectious Diseases, 33 (2), 214-223. doi: 10.1097/QCO.0000000000000627
2020
Journal Article
Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection
McNamara, John F., Avent, Minyon, Stewart, Adam, Kwan, Christopher and Paterson, David L. (2020). Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection. Infection, Disease and Health, 25 (3), 151-157. doi: 10.1016/j.idh.2020.01.003
2020
Journal Article
Initiating tuberculosis treatment at end of life – Balancing patient and infection control interests
Stewart, Adam G. and Wright, Hugh (2020). Initiating tuberculosis treatment at end of life – Balancing patient and infection control interests. Infection, Disease and Health, 25 (4), 283-285. doi: 10.1016/j.idh.2020.05.009
2020
Conference Publication
Molecular epidemiology and hospital spread of ceftriaxone non-susceptible enterobacterales in the Sunshine Coast region, Australia
Stewart, Adam, Sarovich, Derek, Price, Erin, Burnard, Delaney, Harris, Patrick, Choong, Keat and Subedi, Shradha (2020). Molecular epidemiology and hospital spread of ceftriaxone non-susceptible enterobacterales in the Sunshine Coast region, Australia. RACP Congress 2020: Balancing medical science with humanity, Online, May 2020. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/imj.4_14846
2019
Journal Article
Acute kidney injury in acute Q fever
Stewart, Adam G., Broom, Jennifer, Sowden, David and Hollett, Peter (2019). Acute kidney injury in acute Q fever. Internal Medicine Journal, 49 (10), 1326-1329. doi: 10.1111/imj.14447
2019
Journal Article
Inflammatory bowel disease masquerading as traveller's diarrhoea
Stewart, Adam, Sowden, David, Sloss, Andrew and Broom, Jennifer (2019). Inflammatory bowel disease masquerading as traveller's diarrhoea. Internal Medicine Journal, 49 (6), 789-791. doi: 10.1111/imj.14311
2019
Journal Article
The rise and rise of antimicrobial resistance in Gram-negative bacteria
Stewart, Adam, Wright, Hugh and Hajkowicz, Krispin (2019). The rise and rise of antimicrobial resistance in Gram-negative bacteria. Microbiology Australia, 40 (2), 62-65. doi: 10.1071/MA19018
2019
Journal Article
Rhodococcus equi infection: a diverse spectrum of disease
Stewart, Adam, Sowden, David, Caffery, Michael, Bint, Michael and Broom, Jennifer (2019). Rhodococcus equi infection: a diverse spectrum of disease. IDCases, 15 e00487, e00487. doi: 10.1016/j.idcr.2019.e00487
2019
Journal Article
Disseminated Mycobacterium intracellulare from a deep cutaneous infection
Stewart, Adam (2019). Disseminated Mycobacterium intracellulare from a deep cutaneous infection. International journal of mycobacteriology, 8 (1), 98-100. doi: 10.4103/ijmy.ijmy_17_19
2018
Journal Article
Treatment of infections with OXA-48 producing Enterobacteriaceae
Stewart, Adam, Harris, Patrick, Henderson, Andrew and Paterson, David (2018). Treatment of infections with OXA-48 producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 62 (11) e01195-18, AAC.01195-18. doi: 10.1128/aac.01195-18
2018
Journal Article
Heterogeneity in skin manifestations of spotted fever group rickettsial infection in Australia
Stewart, Adam and Hajkowicz, Krispin (2018). Heterogeneity in skin manifestations of spotted fever group rickettsial infection in Australia. The Australasian Journal of Dermatology, 59 (4), 349-351. doi: 10.1111/ajd.12828
Funding
Past funding
Supervision
Availability
- Dr Adam Stewart is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
Contact Dr Adam Stewart directly for media enquiries about:
- clinical trial
- infectious diseases
- superbugs
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: